The South Africa Head and Neck Cancer Therapeutics Market was valued at $30.50 Mn in 2023 and is predicted to grow at a CAGR of 13.50% from 2023 to 2030, to $74.01 Mn by 2030. The key drivers of this industry include the aging population, advancement in treatment, and government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
South Africa Genomic Diagnostics Market was valued at $212.23 Mn in 2023 and is predicted to grow at a CAGR of 17.73% from 2023 to 2030, to $665.28 Mn by 2030. The key drivers of this industry include increasing prevalence, technological advancements, and demand for personalized medicine. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
South Africa Compression Therapy Market was valued at $25 Mn in 2022 and is estimated to reach $42 Mn in 2030, exhibiting a CAGR of 6.83% during the forecast period. The increasing incidence of venous disorders, including leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots, is a major factor contributing to the expansion of the compression therapy market. Leading companies in this sector include Mölnlycke Health Care, Sigvaris Group, Medi GmbH & Co., Bauerfeind, BSN Medical, Hartmann Group, Medi-Globe Pharmaceuticals, Aspen Pharmacare, FBNQuest Healthcare, and Juzo.
The South Africa Mouth Ulcer Therapeutics Market was valued at $9.9 Mn in 2023 and is projected to grow at a CAGR of 5.13% from 2023 to 2023, to $14 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Aspen Pharmacare, Cipla Medpro, Sanofi, GlaxoSmithKline PLC, Pfizer, Inc. among others.
The South Africa Bariatric Surgery Devices Marketwas valued at $17.3 Mn in 2023 and is projected to grow at a CAGR of 6.43% from 2023 to 2023, to $26.8 Mn by 2030. The market for bariatric surgical devices is being driven primarily by increased adult obesity rates, which are a result of changing lifestyles and consuming excessive amounts of calories. Over the course of the projection period, it is also expected that the demand for bariatric operations will increase as a result of growing public awareness of the harmful food and beverage options available in the market and how they affect body mass index (BMI), which will fuel the expansion of the bariatric surgery devices market. The prominent players in the market are Apollo Endosurgery, Medtronic, ReShape Lifesciences, Johnson & Johnson, Cousin Biotech among others.
South Africa CT Scan Market was valued at $29.97 Mn in 2023 and is predicted to grow at a CAGR of 9.1% from 2023 to 2030, to $55.13 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, the growing population, and increased healthcare spending. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and Koninklijke Philips, among others.
South Africa Lipid Disorder Therapeutics Market was valued at $252.5 Mn in 2023 and is predicted to grow at a CAGR of 13.63% from 2023 to 2030, to $617.6 Mn by 2030. South Africa Lipid Disorder Therapeutics Market is growing due to Advancements in Therapeutics, Increasing Healthcare Expenditure, and the Rising Prevalence of Cardiovascular Diseases (CVDs). The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
The South Africa Bio-implant Market was valued at $422.5 Mn in 2023 and is predicted to grow at a CAGR of 7.13% from 2023 to 2030, to $684.2 Mn by 2030. The South Africa Bio-implant Market is growing due to Private Healthcare Sector Expansion, Government Initiatives and Healthcare Spending, Prevalence of Chronic Diseases. The market is primarily dominated by players such as Teleflex, CapeRay, DISA Vascular, TiTaMED, Sinapi Biomedical, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
The South Africa Mental Health Apps Market was valued at $40.3 Mn in 2023 and is predicted to grow at a CAGR of 16.43% from 2023 to 2030, to $116.89 Mn by 2030. The key drivers of this industry include a shortage of professionals, rising awareness, and increasing smartphone penetration. The industry is primarily dominated by players such as Remente, Breathe2Relax, SuperBetter, and Pacifica among others.
South Africa Actinic Keratosis Therapeutic Market is expected to expand at a CAGR of 6.13% from $44 Mn in 2022 to $71 Mn by 2030. The South Africa Actinic Keratosis Therapeutic Market is poised for continued growth, driven by rising awareness, technological advancements, and an expanding healthcare sector and addressing access and affordability challenges will be crucial to ensure optimal market growth. Global giants like Galderma, Meda Pharmaceuticals, Merck & Co, Bausch, GlaxoSmithCline, etx coexist with smaller regional firms like Aspen Pharmacare, Adcock Ingram, Biovac, Clinitec etc as major participants in the South Africa, which is constantly changing
South Africa Constipation Therapeutics Market was valued at $118 Mn in 2022 and is estimated to reach $215 Mn in 2030, exhibiting a CAGR of 7.73% during the forecast period. The constipation therapeutics market is experiencing worldwide expansion due to factors like aging, sedentary lifestyles, and poor dietary habits. The growing elderly demographic, prone to chronic conditions, plays a significant role in driving this growth. Key players in this industry include AstraZeneca, Bayer AG, Sanofi, Sucampo Pharmaceuticals, Takeda Pharmaceutical, Synergy Pharmaceuticals, Ironwood Pharmaceuticals, Salix Pharmaceuticals, Abbott Laboratories and Cosmo Pharmaceuticals NV.
The South Africa Herbal Supplements Market was valued at $34.19 Mn in 2023 and is predicted to grow at a CAGR of 7.43% from 2023 to 2030, to $56.46 Mn by 2030. The key drivers of this industry include the prevalence of chronic disease, growing health awareness, and a shift towards a healthy lifestyle. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, NOW Foods, Botanic Supplements, and Dabur among others.
South Africa Clinical Nutrition for Chronic Kidney Diseases Market was valued at $ 10.20 Mn in 2023 and is predicted to grow at a CAGR of 7.26 % from 2023 to 2030, to $ 16.70 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and increasing healthcare expenditure. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
The South Africa Brugada Syndrome Market was valued at $7.8 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $14.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, aging population, and advancements in genetic testing. The prominent players of the South Africa Brugada Syndrome Market are Sun Pharma, Cipla, Bayer, Sanofi, Aspen Pharmacare, Astellas, and Medtronic, among others.
South Africa Blood Disorder Therapeutics Market valued at $87 Mn in 2022, projected to reach $170 Mn by 2030 with a 8.37% CAGR. The key drivers include the implementation of initiatives like collaborative efforts between government agencies, NGOs, and pharmaceutical businesses, demographic factors influencing blood disorders prevalence, and the anticipation of introducing novel therapies, leading to increased research, development, and infrastructure investments in the field. The South Africa Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Pfizer, AstraZeneca, Sanofi, Aspen, Adcock Ingram, Eisai, BGM, Gilead Sciences, Sunrise Pharmaceuticals etc, among various others.
South Africa Dental Endodontics Market was valued at $11.40 Mn in 2023 and is predicted to grow at a CAGR of 5.53% from 2023 to 2030, to $16.60 Mn by 2030. The key drivers of this industry include rising awareness of oral health, a growing geriatric population, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
The South Africa Clinical Nutrition Market was valued at $199.4 Mn in 2023 and is projected to grow at a CAGR of 6.57% from 2023 to 2023, to $311.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Herbalife Nutrition, Optimum Nutrition, Abbott Nutrition, Pfizer Inc, Nestle, Mead Johnson & Company, LLC among others.
The South Africa Breast Pump Market was valued at $19.1 Mn in 2023 and is predicted to grow at a CAGR of 9.83% from 2023 to 2030, to $36.8 Mn by 2030. The key drivers of the market include the rising female workforce, technological features, and growing awareness. The prominent players in the South Africa Breast Pump Market are Bistos, Ameda, Avent, Evenflo, and Pigeon, among others.
South Africa Cardiac Resynchronization Therapy Market valued at $31 Mn in 2022, projected to reach $51 Mn by 2030 with a 6.23% CAGR. The significant rise in global heart failure instances, linked to the aging population and cardiovascular issues related to lifestyle, plays a crucial role in propelling the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, major players in this market include Abbott, Boston Scientific, Medtronic, Biotronik, Siemens Healthineers, St. Jude Medical, LivaNova, Sorin Group, Oscor, and Lepu Medical Technology.
The South Africa Exosome Research Market was valued at $1.1 Mn in 2023 and is projected to grow at a CAGR of 17.23% from 2023 to 2023, to $3.3 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, and increasing advanced applications of exosomes. The industry is primarily dominated by players such as Hologic Inc., Luminex Corporation, QIAGEN, Agilent Technologies among others.
South Africa Digital Biomarkers Market was valued at $18.85 Mn in 2023 and is predicted to grow at a CAGR of 23.53% from 2023 to 2030, to $82.74 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, rising healthcare costs, and an aging population. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
The South Africa Medication Access Programs Market was valued at $35.7 Mn in 2023 and is predicted to grow at a CAGR of 15.83% from 2023 to 2030, to $99.8 Mn by 2030. The key drivers of this industry include disease burden, government initiatives, and healthcare infrastructure. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
South Africa Cancer Induced Bone Diseases Therapeutics Market valued at $8 Mn in 2022, projected to reach $15 Mn by 2030 with a 7.03% CAGR. The key drivers of this industry include the rising burden of cancer, increased healthcare spending, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Fresenius, AstraZeneca, Merck, Eli Lilly, Johnson & Johnson, Amgen, and Novartis among others.
The South Africa Physiotherapy Equipment Market was valued at $135.85 Mn in 2023 and is predicted to grow at a CAGR of 8.43% from 2023 to 2030, to $239.39 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are HMS Medical Systems, BTL Industries, EMS Physio Ltd., and Enraf-Nonius BV among others.
The South Africa Dental Consumables Market was valued at $219.7 Mn in 2023 and is projected to grow at a CAGR of 9.23% from 2023 to 2023, to $407.6 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Dentsply Sirona, Danaher, GC Corporation, 3M, Henry Schein, Osstem Implant among others.